aTyr Pharma | LIFE - Current Assets

Stock Price
0.79
Daily Change
-0.01 -0.85%
Monthly
-1.79%
Yearly
-76.57%
Q2 Forecast
0.77

aTyr Pharma reported $245.8M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Ardelyx USD 382.32M 14.33M Dec/2025
aTyr Pharma USD 245.8M 152.79M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025